Publicaciones en colaboración con investigadores/as de Hospital Universitario La Paz (5)

2023

  1. Corrigendum: The paradigm of IL-23-independent production of IL-17F and IL-17A and their role in chronic inflammatory diseases(Front. Immunol., (2023), 14, (1191782), 10.3389/fimmu.2023.1191782)

    Frontiers in Immunology

  2. Effectiveness and safety of tildrakizumab for the treatment of psoriasis in real-world settings at 24 weeks: A retrospective, observational, multicentre study by the Spanish Psoriasis Group

    Journal of the European Academy of Dermatology and Venereology, Vol. 37, Núm. 12, pp. 2517-2525

  3. The paradigm of IL-23-independent production of IL-17F and IL-17A and their role in chronic inflammatory diseases

    Frontiers in Immunology, Vol. 14

2021

  1. SARS-CoV-2-induced telogen effluvium: a multicentric study

    Journal of the European Academy of Dermatology and Venereology

2019

  1. Referral of Patients to Dermatology and Teledermatology Consultations in Spain. DIADERM Study

    Actas Dermo-Sifiliograficas, Vol. 110, Núm. 2, pp. 146-152